Dominic Clarke

Dominic Clarke

Company: Discovery Life Sciences

Job title: Chief Technical Officer of
Cell & Gene Therapies

Bio:

Dr. Clarke has over 15 years of experience developing enabling solutions to support cell and gene therapies. Dominic is currently the Chief Technical Officer, for Cell & Gene Therapies at Discovery Life Sciences, where he is responsible for providing leadership and direction on their current and future products & services roadmap and overall strategy in CGT.   

Previous roles include Director of Global Cell Therapy Strategy & Innovation at HemaCare and Charles River Laboratories, Global Product Manager for Charter Medical’s cell therapy and bioprocessing single-use systems portfolio and Director of Research and Development for BioLife Solutions. 

Dominic currently serves as the co-chair for the International Society for Cell and Gene Therapies Process and Product Development Committee with efforts directed towards translating research and process development from bench to clinic.   

Seminars:

Panel Discussion & Q&A: Optimizing Next Generation Cell Therapy Starting Materials 6:35 pm

• Discuss how pre-characterized human cellular materials will accelerate cell therapy development • Address the ever-increasing demand for cellular starting materials and review how to increase specific sample cohorts • Deep dive into the benefits of comprehensive multi-omic services and how it can streamline and accelerate cell therapy research • Hear how Discovery Life Sciences…Read more

day: CANCELLED: Recent Advances in Scalable Manufacturing of Cell & Gene Therapies

How the Right Starting Materials Can Deliver a Higher Probability of Attaining Cell & Gene Therapy Manufacturing Success 11:45 am

Outline how characterized donor source materials can impact consistency from process development to manufacturing Strategies for building efficiencies and alleviate bottlenecks by implementing cryopreserved leukapheresis Requirements to delivering a sustainable starting material supply chain for large-scale allogeneic therapiesRead more

day: Agenda: Next Generation of Cell Therapies: Combined Analytics & Cryopreserved Starting Materials

Live Audience Q&A 12:05 pm

Read more

day: Agenda: Next Generation of Cell Therapies: Combined Analytics & Cryopreserved Starting Materials

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.